Isavuconazole Terminated Phase 2 Trials for Invasive Aspergillosis / Pulmonary Invasive Aspergillosis Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03327727VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults